Article
The hexokinase “HKDC1” interaction with the mitochondria is essential for liver cancer progression
28 Jul 2022
Abstract excerpt
Liver cancer (LC) is the fourth leading cause of death from cancer malignancies. Recently, a putative fifth hexokinase, hexokinase domain containing 1 (HKDC1), was shown to have significant overexpression in LC compared to healthy liver tissue. Using a combination of in vitro and in vivo tools, we examined the role of HKDC1 in LC development and progression. Importantly, HKDC1 ablation stops LC development and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
